Valborg Vang Poulsen
Research Subjects
Valborg Vang Poulsen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- John Gásdal Karstensen
University of Copenhagen, Denmark
2 shared publications Amer Hadi
Pancreatitis Centre East, Gastrounit, Copenhagen University Hospital – Amager and Hvidovre, Copenhagen, Denmark
1 shared publication- Amer Hadi
Pancreatitis Centre East (PACE), Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre, Denmark
1 shared publication Annette Bøjer Jensen
Department of Radiology, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
1 shared publicationMia Prindahl Ærenlund
Pancreatitis Centre East, Gastrounit, Copenhagen University Hospital – Amager and Hvidovre, Copenhagen, Denmark
1 shared publication- Mikkel Parsberg Werge
Gastro Unit, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark
1 shared publication
Latest Publications
- Open Access
- 18 February 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 239
Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis—A Literature Review
Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.
- 18 February 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 239
Open AccessCirculating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis—A Literature Review
Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.
- Open Access
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E354-E355
Pancreatic-portal vein fistula in acute pancreatitis successfully treated with endoscopic approach
Acute pancreatitis is associated with numerous complications. Pancreatic-portal vein fistula (PPVF) is an exceptionally rare and diagnostically challenging example [1] [2]. A 63-year-old man was admitted due to abdominal pain, weight loss, newly diagnosed diabetes, and elevated liver enzymes. Contrast-enhanced computed tomography revealed acute pancreatitis with fluid exudation and a necrotic collection in the head of the pancreas, accompanied by attenuation of fluid in the portal vein. Subsequent magnetic resonance cholangiopancreatography raised suspicion of PPVF. Endoscopic retrograde cholangiopancreatography (ERCP) identified a stenosis in the pancreatic duct (PD) at the head of the pancreas, associated with an upstream fluid collection and a fistula into the portal vein. The PD was not visible as the contrast injection passed into the portal vein ([Video 1]). The therapeutic intervention included pancreatic sphincterotomy with dilation of the PD stenosis with a 6-mm balloon catheter. Two 7 cm × 7 Fr double-pigtail stents were positioned within the fluid collection. The patient developed septicemia, which was treated with antibiotics. The patient was discharged after 45 days of hospitalization. At ERCP 2 months later, no communication between the PD and portal vein was evident, but the stenosis of the PD had recurred ([Fig. 1]). The stenosis was dilated using a 4-mm balloon catheter, and one 7-Fr and one 5-Fr pancreatic stent were placed. The stents were replaced biannually during the following 12 months. There was no sign of PPVF, and the PD was patent, without stenosis. At 2.5 years’ follow-up, the patient was asymptomatic regarding acute pancreatitis and PPVF. This case highlights the importance of recognizing PPVF as a potential complication of acute pancreatitis and not solely associated with chronic pancreatitis. The patient’s long-term survival underscores the significance of tailored interventions achieving favorable outcomes in complex complications of acute pancreatitis. Endoscopy_UCTN_Code_CCL_1AZ_2AH Article published online: 25 April 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E354-E355
Open AccessPancreatic-portal vein fistula in acute pancreatitis successfully treated with endoscopic approach
Acute pancreatitis is associated with numerous complications. Pancreatic-portal vein fistula (PPVF) is an exceptionally rare and diagnostically challenging example [1] [2]. A 63-year-old man was admitted due to abdominal pain, weight loss, newly diagnosed diabetes, and elevated liver enzymes. Contrast-enhanced computed tomography revealed acute pancreatitis with fluid exudation and a necrotic collection in the head of the pancreas, accompanied by attenuation of fluid in the portal vein. Subsequent magnetic resonance cholangiopancreatography raised suspicion of PPVF. Endoscopic retrograde cholangiopancreatography (ERCP) identified a stenosis in the pancreatic duct (PD) at the head of the pancreas, associated with an upstream fluid collection and a fistula into the portal vein. The PD was not visible as the contrast injection passed into the portal vein ([Video 1]). The therapeutic intervention included pancreatic sphincterotomy with dilation of the PD stenosis with a 6-mm balloon catheter. Two 7 cm × 7 Fr double-pigtail stents were positioned within the fluid collection. The patient developed septicemia, which was treated with antibiotics. The patient was discharged after 45 days of hospitalization. At ERCP 2 months later, no communication between the PD and portal vein was evident, but the stenosis of the PD had recurred ([Fig. 1]). The stenosis was dilated using a 4-mm balloon catheter, and one 7-Fr and one 5-Fr pancreatic stent were placed. The stents were replaced biannually during the following 12 months. There was no sign of PPVF, and the PD was patent, without stenosis. At 2.5 years’ follow-up, the patient was asymptomatic regarding acute pancreatitis and PPVF. This case highlights the importance of recognizing PPVF as a potential complication of acute pancreatitis and not solely associated with chronic pancreatitis. The patient’s long-term survival underscores the significance of tailored interventions achieving favorable outcomes in complex complications of acute pancreatitis. Endoscopy_UCTN_Code_CCL_1AZ_2AH Article published online: 25 April 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany